The prognostic significance and Immunomodulatory role of SCGB3A1 expression in stage I lung adenocarcinoma
Abstract Background Many early-stage lung adenocarcinoma patients experience recurrence or metastasis after surgery, and the efficacy of targeted therapies remains suboptimal, significantly impacting the prognosis of these patients. Our study aims to investigate the impact of SCGB3A1 on the prognosi...
Saved in:
| Main Authors: | Xin Zhang, ShiNing Li, Yujin Lv, XinYu Liu, Yong Ao, LeQi Zhong, Yi Hu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Medical Genomics |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12920-025-02192-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of the prognostic and immune role of MCM6 in pan-cancer and experimental validation in lung adenocarcinoma cells
by: Minghua Liao, et al.
Published: (2025-08-01) -
Systematic pan-cancer analysis identified NCOA4 as an immunological and prognostic biomarker and validated in lung adenocarcinoma
by: An Wang, et al.
Published: (2025-07-01) -
Epithelial zinc finger protein in lung adenocarcinoma: prognostic biomarker with molecular and clinical implications
by: Xiaofen Wen, et al.
Published: (2025-06-01) -
PTPRC is an immunotherapeutic predictor and serum biomarker in lung adenocarcinoma correlated with immune cell infiltration
by: Yongwang Hou, et al.
Published: (2025-08-01) -
Unraveling disulfidptosis for prognostic modeling and personalized treatment strategies in lung adenocarcinoma
by: Xiangyu Xu, et al.
Published: (2024-12-01)